Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gasser

Showing results (361-370 of 421) with videos related to

Pageof 43
Sort By:
Science Translational Medicine|September 10, 2020
A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson's diseaseIbrahim Boussaad, Carolin D Obermaier, Zoé Hanss, et al.
Neurology|May 13, 2018
Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2Erik Boot, Nancy J Butcher, Sean Udow, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2024
Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global ScaleJohanna Junker, Lara M Lange, Eva-Juliane Vollstedt, et al.
The Journal of Clinical Investigation|February 4, 2021
Biallelic variants in TSPOAP1, encoding the active-zone protein RIMBP1, cause autosomal recessive dystoniaNiccolò E Mencacci, Marisa M Brockmann, Jinye Dai, et al.
American Journal of Human Genetics|May 19, 2015
A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystoniaNiccolo E Mencacci, Ignacio Rubio-Agusti, Anselm Zdebik, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2008
Red flags for multiple system atrophyMartin Köllensperger, Felix Geser, Klaus Seppi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 26, 2024
Understanding monogenic Parkinson's disease at a global scaleJohanna Junker, Lara M Lange, Eva-Juliane Vollstedt, et al.
European Journal of Human Genetics : EJHG|December 8, 2005
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's diseaseAlessio Di Fonzo, Cristina Tassorelli, Michele De Mari, et al.
Neurobiology of Aging|September 3, 2020
Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's diseaseEmmeline E Brown, Cornelis Blauwendraat, Joanne Trinh, et al.
Annals of Neurology|May 29, 2009
SNCA variants are associated with increased risk for multiple system atrophySonja W Scholz, Henry Houlden, Claudia Schulte, et al.
Pageof 43

Showing results (361-370 of 421) with videos related to

Sort By:
Pageof 43
Science Translational Medicine|September 10, 2020
A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson's diseaseIbrahim Boussaad, Carolin D Obermaier, Zoé Hanss, et al.
Neurology|May 13, 2018
Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2Erik Boot, Nancy J Butcher, Sean Udow, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2024
Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global ScaleJohanna Junker, Lara M Lange, Eva-Juliane Vollstedt, et al.
The Journal of Clinical Investigation|February 4, 2021
Biallelic variants in TSPOAP1, encoding the active-zone protein RIMBP1, cause autosomal recessive dystoniaNiccolò E Mencacci, Marisa M Brockmann, Jinye Dai, et al.
American Journal of Human Genetics|May 19, 2015
A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystoniaNiccolo E Mencacci, Ignacio Rubio-Agusti, Anselm Zdebik, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2008
Red flags for multiple system atrophyMartin Köllensperger, Felix Geser, Klaus Seppi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 26, 2024
Understanding monogenic Parkinson's disease at a global scaleJohanna Junker, Lara M Lange, Eva-Juliane Vollstedt, et al.
European Journal of Human Genetics : EJHG|December 8, 2005
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's diseaseAlessio Di Fonzo, Cristina Tassorelli, Michele De Mari, et al.
Neurobiology of Aging|September 3, 2020
Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's diseaseEmmeline E Brown, Cornelis Blauwendraat, Joanne Trinh, et al.
Annals of Neurology|May 29, 2009
SNCA variants are associated with increased risk for multiple system atrophySonja W Scholz, Henry Houlden, Claudia Schulte, et al.
Pageof 43